Join to View Full Profile
720 Eskenazi AveIndianapolis, IN 46202
Phone+1 317-880-8329
Fax+1 305-243-8470
Dr. Regev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1988
Certifications & Licensure
IN State Medical License 2007 - 2025
FL State Medical License 2001 - 2007
Publications & Presentations
PubMed
- 1 citationsAssessment of liver injury potential of investigational medicines in drug development.Naga Chalasani, Paul H Hayashi, Debra Luffer-Atlas, Arie Regev, Paul B Watkins
Hepatology. 2025-02-25 - Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.Anna Fettiplace, John Marcinak, Michael Merz, Hui-Talia Zhang, Luciana Kikuchi
Alimentary Pharmacology & Therapeutics. 2024-11-01 - Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study.Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster
Clinical Pharmacology and Therapeutics. 2024-05-01
Other
- Diagnosis and management of cystic lesions of the liverRegev A, Reddy KR
http://www.uptodate.com/contents/diagnosis-and-management-of-cystic-lesions-of-the-liver
UpToDate, Wolters Kluwer Health - 2013-03-22
Press Mentions
Consensus: Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Patients with Nonalcoholic SteatohepatitisFebruary 13th, 2020
Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisFebruary 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
